Sasaki, Ryu Yamasaki, Kazumi Abiru, Seigo Komori, Atsumasa Nagaoka, Shinya Saeki, Akira Hashimoto, Satoru Bekki, Shigemune Kugiyama, Yuki Kuno, Atsushi Korenaga, Masaaki Togayachi, Akira Ocho, Makoto Mizokami, Masashi Narimatsu, Hisashi Ichikawa, Tatsuki Nakao, Kazuhiko Yatsuhashi, Hiroshi Cumulative incidence of hepatocellular carcinoma (HCC) according to post-treatment WFA<sup>+</sup>-M2BP values, stratified by stage of fibrosis. <p>(A): F1/2 (n = 172). (B): F3/4 (n = 66). Cumulative incidences of HCC according to post-treatment WFA<sup>+</sup>-M2BP values were analyzed using the Kaplan-Meier method. The black solid and dotted lines indicate the stratified post-treatment WFA<sup>+</sup>-M2BP values with a COI ≤ 2.0 and a COI > 2.0, respectively. There were no significant differences in HCC incidence with F1/2 group (<i>P</i> = 0.09 by the log-rank test). On the other hand, the incidence rate differed significantly with F3/4 group (<i>P</i> < 0.01 by the log-rank test). The numbers of patients at risk at each time point are shown below the graphs.</p> svr;238 patients;wfa;12.04 cutoff index;Sustained Virological Response Measurement;hcc;Chronic hepatitis C;2.0 COI 2015-06-12
    https://plos.figshare.com/articles/figure/_Cumulative_incidence_of_hepatocellular_carcinoma_HCC_according_to_post_treatment_WFA_M2BP_values_stratified_by_stage_of_fibrosis_/1448163
10.1371/journal.pone.0129053.g003